SUBSCRIBE

Clinical data requirements for biosimilars in the EU

 Posted 11/10/2019

In their article [1], authors from the Paul-Ehrlich-Institut, the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (Bf...

more
FDA approves Pfenex’s follow-on teriparatide pr... Biosimilars/News | Posted 11/10/2019
EMA provides guidance on avoiding nitrosamines... Guidelines | Posted 11/10/2019
Biocon/Mylan launch first insulin glargine bios... Biosimilars/News | Posted 11/10/2019
FDA releases new patient guidance on biosimilars Biosimilars/General | Posted 11/10/2019
Adalimumab copy biological shown to be safe and... Biosimilars/Research | Posted 11/10/2019
Strong generics nocebo effect found in US Generics/Research | Posted 11/10/2019
AB004665
Alimta and Orfadin generics approved by FDA Generics/News | Posted 11/10/2019
ST002293
Biosimilars applications reviewed in the EU Biosimilars/Research | Posted 04/10/2019
Three darbepoetin alfa biosimilars approved in... Biosimilars/News | Posted 04/10/2019
Novo Nordisk to launch biosimilar insulin in th... Biosimilars/General | Posted 04/10/2019
iBio and CC-Pharming collaborate for rituximab... Biosimilars/News | Posted 04/10/2019
Switching from originator to biosimilar epoetin... Biosimilars/Research | Posted 04/10/2019
New evidence: comparable clinical outcomes for... Generics/Research | Posted 04/10/2019
Celltrion contracts Lonza to manufacture autoim... Pharma News | Posted 04/10/2019
Carcinogen contamination halts distribution of... Generics/General | Posted 04/10/2019
Positive EMA-CHMP opinion for SC infliximab bio... Biosimilars/News | Posted 27/09/2019
Mylan’s insulin biosimilar blocked, but wins pa... Biosimilars/General | Posted 27/09/2019
Shanghai Pharma and Russia’s Biocad form joint... Pharma News | Posted 27/09/2019
Samsung Bioepis to supply Brenzys to Brazil und... Biosimilars/News | Posted 27/09/2019
Switching from originator infliximab to CT-P13:... Biosimilars/Research | Posted 27/09/2019
Evaluating success: generics substitution polic... Generics/Research | Posted 27/09/2019
AB004665
EMA approves leukaemia and multiple myeloma gen... Generics/News | Posted 27/09/2019
A call to end US drug pricing games Policies & Legislation | Posted 27/09/2019
20920796_l
Trastuzumab biosimilar Herzuma approved in Canada Biosimilars/News | Posted 20/09/2019
UnitedHealthcare to preferentially cover Amgen’... Biosimilars/General | Posted 20/09/2019
China approves new formulation of etanercept co... Biosimilars/News | Posted 20/09/2019
FDA’s global inspection strategy strengthened Generics/General | Posted 20/09/2019
Generics in Chile: policy success but promotion... Generics/Research | Posted 20/09/2019
Sandoz makes deal with Polpharma for natalizuma... Pharma News | Posted 20/09/2019
Screening protein surface biosimilarity of ritu... Biosimilars/Research | Posted 20/09/2019
China eases generic medicine import laws Policies & Legislation | Posted 20/09/2019
Canadian IBD charity updates biosimilar positio... Biosimilars/General | Posted 13/09/2019
Herzuma gains Japanese approval for three-week... Biosimilars/News | Posted 13/09/2019
TRIPS flexibilities: current and future use in... Generics/Research | Posted 13/09/2019
20920796_l
More positive phase III results for rituximab b... Biosimilars/Research | Posted 13/09/2019
Huons enters biosimilar market while private eq... Pharma News | Posted 13/09/2019
FDA organizes workshop on complex generics Guidelines | Posted 13/09/2019
Clinical comparability between rituximab biosim... Biosimilars/Research | Posted 13/09/2019
Revance Therapeutics focus on its own Botox bio... Biosimilars/News | Posted 13/09/2019
16704526_l
Challenges for European pharmacovigilance Reports | Posted 06/09/2019
Teriparatide biosimilar Terrosa launched in Europe Biosimilars/News | Posted 06/09/2019
Improving access to medicines: the Doha Declara... Generics/Research | Posted 06/09/2019
Praise for Canada’s BC after it adopts biosimil... Policies & Legislation | Posted 06/09/2019
Switching from reference to biosimilar inflixim... Biosimilars/Research | Posted 06/09/2019
Court rules Amgen’s patents on Enbrel are valid... Biosimilars/General | Posted 06/09/2019
Positive results for Bio-Thera’s arthritis copy... Biosimilars/Research | Posted 06/09/2019
Mylan launches adalimumab biosimilar Hulio in S... Biosimilars/News | Posted 06/09/2019
Perceptions of biosimilars among US cancer pati... Biosimilars/Research | Posted 30/08/2019
Heparin biosimilar to be marketed in Canada Biosimilars/News | Posted 30/08/2019
more

NON-BIOLOGICAL COMPLEX DRUGS

FDA issues final guidance on liposome drug products Posted 27/04/2018

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft...

more


FDA approves 40 mg follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 09/03/2018
Mylan launches first follow-on glatiramer aceta... Non‐Biological Complex Drugs/News | Posted 15/02/2018
Biosimilars and follow-on NBCDs for MS in Europ... Non‐Biological Complex Drugs/Research | Posted 19/01/2018
Impax announces FDA approval of follow-on sevel... Non‐Biological Complex Drugs/News | Posted 17/11/2017
FDA approves follow-on version of sevelamer Non‐Biological Complex Drugs/News | Posted 30/06/2017
Challenges in the regulation of NBCDs Non‐Biological Complex Drugs/Research | Posted 12/05/2017
Scientific and regulatory considerations for fo... Non‐Biological Complex Drugs/Research | Posted 05/05/2017
Equivalence of complex drug products Non‐Biological Complex Drugs/Reports | Posted 14/04/2017
Follow-up studies needed to ensure safety for f... Non‐Biological Complex Drugs/Research | Posted 31/03/2017
Warning letter causes delays for follow-on glat... Non‐Biological Complex Drugs/News | Posted 17/03/2017
Is the EU ready for non-biological complex drug... Non‐Biological Complex Drugs/Research | Posted 03/03/2017
Follow-on versions of glatiramer acetate in Rus... Non‐Biological Complex Drugs/News | Posted 24/02/2017
Non-biological complex drugs and pharmacopoeias Non‐Biological Complex Drugs/Research | Posted 10/02/2017
In vitro analysis of follow-on versions of seve... Non‐Biological Complex Drugs/Research | Posted 18/11/2016
Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections